Last $4.90 USD
Change Today +0.0302 / 0.62%
Volume 271.3K
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:32 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan N. Houghton M.D.

Former Chairman of Cancer Scientific Advisory Board, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 120 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Alan N. Houghton, M.D. is a Professor of Weill/Cornell Medical College (WCMC). Dr. Houghton serves as the Chairman of Immunology Program, Sloan-Kettering. Dr. Houghton served as the Chairman of Cancer Scientific Advisory Board at Progenics Pharmaceuticals Inc. He serves as a Member of Scientific Advisory Council at Cancer Research Institute, Inc.

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $4.90 USD +0.0302

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.